群創生技公司致力於透過創新核子醫學的標靶分子診斷和治療來改善惡性疾病患者的生活。AITP is devoted to improving the life of patients with malignant diseases through targeted molecular diagnostic and therapy based on innovative nuclear medicine.
群創生技公司設立的熱情與目標，將對準核醫精準醫療新藥快速進入臨床，以提早符合癌症患者臨床之未滿足需求。
AITP’s passion and goal will be to rapidly clinically target new nuclear medicine precision medicine drugs in the early stages to meet the unmet clinical needs of cancer patients as early as possible.
